Conservative Treatment of Esotropia in Children up to 3 Years Old

Prescription of Full Optical Correction in Refractive Errors to Treat Esotropia in Children up to 3 Years Old

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT02404324

Enrollment

150

Registered

2015-03-31

Start date

2012-01-31

Completion date

2017-11-30

Last updated

2017-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Esotropia

Brief summary

The objective of this prospective study is the treatment of esotropia by prescribing the full precise optical correction of refractive errors in children up to 3 years old.

Detailed description

This investigation includes children with esotropia associated with hyperopia, hypermetropic astigmatism, myopia, myopic astigmatism and minor ametropias. All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dpt to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization were administered to the children. The investigators suggest that this approach will give good results in the treatment of esotropia.

Interventions

OTHERPrescription of spectacles

All children are prescribed full optical correction of refractive errors with special attention to astigmatism up to 0.5 Dptr to achieve maximal clear image on the retina of both eyes.If necessary, direct occlusion or penalization are administered to the children.

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

3 Months to 3 Years

Healthy volunteers

Inclusion criteria

* Within the age of 3 months to 3 years (inclusive infantile esotropia) * Patients with constant or periodic esotropia and with revealed angle of deviation 5 degrees or over by Hirschberg test * Patients with refractive errors (inclusive minor ametropias from 0.5 Dptr)

Exclusion criteria

* Age above 3 years * Patients with neurological diseases and paralytic strabismus

Design outcomes

Primary

Measure	Time frame	Description
The angle of deviation	2 years	The absolute success is defined as restored symmetrical eye position.Qualified success is considered as reduction of the angle of deviation. Patients are examined 24 months later to assess outcome of treatment.

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026